The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2-(2-carboxyethyl)-3-(6-(5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4'-fluorobiphenyl-3-yloxy)hexyl)phenoxy)butanoic acid ID: ALA1094350
PubChem CID: 46888202
Max Phase: Preclinical
Molecular Formula: C39H41FO8
Molecular Weight: 656.75
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3ccc(F)cc3)cc(-c3ccc4c(c3)OCCO4)c2)c1CCC(=O)O
Standard InChI: InChI=1S/C39H41FO8/c40-32-14-11-27(12-15-32)30-23-31(29-13-17-36-37(26-29)48-22-21-47-36)25-33(24-30)45-19-4-2-1-3-7-28-8-5-9-35(34(28)16-18-39(43)44)46-20-6-10-38(41)42/h5,8-9,11-15,17,23-26H,1-4,6-7,10,16,18-22H2,(H,41,42)(H,43,44)
Standard InChI Key: UFUBKPHWMFMDPY-UHFFFAOYSA-N
Molfile:
RDKit 2D
48 52 0 0 0 0 0 0 0 0999 V2000
7.8444 -2.9041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8432 -3.7315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5581 -4.1444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2745 -3.7310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2716 -2.9005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5563 -2.4914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9896 -4.1424 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7034 -3.7288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4186 -4.1402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1324 -3.7265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8475 -4.1379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5613 -3.7243 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8488 -4.9629 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5579 -4.9694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2722 -5.3820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2720 -6.2070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9864 -6.6197 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5575 -6.6194 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1284 -4.1434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4143 -3.7304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6995 -4.1423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9854 -3.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2706 -4.1412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5564 -3.7281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8416 -4.1400 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1275 -3.7270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1292 -2.9029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7021 -3.7311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4160 -4.1404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7001 -2.9019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4168 -2.4915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4163 -1.6712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0085 -4.1488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7244 -3.7365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7148 -5.3865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0049 -4.9704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1283 -1.2623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1282 -0.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4170 -0.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7044 -0.4471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7081 -1.2654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4154 0.7929 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.4331 -4.9775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4375 -4.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1558 -3.7364 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8744 -4.1536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8699 -4.9852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1470 -5.3994 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25 26 1 0
11 13 2 0
26 27 2 0
27 31 1 0
1 2 2 0
30 28 1 0
3 14 1 0
28 29 2 0
29 26 1 0
4 7 1 0
14 15 1 0
30 31 2 0
3 4 2 0
31 32 1 0
15 16 1 0
7 8 1 0
33 34 2 0
34 44 1 0
16 17 1 0
43 35 1 0
35 36 2 0
36 33 1 0
28 33 1 0
16 18 2 0
8 9 1 0
2 19 1 0
4 5 1 0
19 20 1 0
9 10 1 0
32 37 2 0
20 21 1 0
37 38 1 0
2 3 1 0
38 39 2 0
21 22 1 0
39 40 1 0
10 11 1 0
40 41 2 0
41 32 1 0
22 23 1 0
39 42 1 0
43 44 2 0
5 6 2 0
23 24 1 0
11 12 1 0
24 25 1 0
6 1 1 0
43 48 1 0
44 45 1 0
45 46 1 0
46 47 1 0
47 48 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 656.75Molecular Weight (Monoisotopic): 656.2785AlogP: 8.37#Rotatable Bonds: 18Polar Surface Area: 111.52Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 4.12CX Basic pKa: ┄CX LogP: 8.49CX LogD: 2.76Aromatic Rings: 4Heavy Atoms: 48QED Weighted: 0.10Np Likeness Score: -0.29
References 1. Goodnow RA, Hicks A, Sidduri A, Kowalczyk A, Dominique R, Qiao Q, Lou JP, Gillespie P, Fotouhi N, Tilley J, Cohen N, Choudhry S, Cavallo G, Tannu SA, Ventre JD, Lavelle D, Tare NS, Oh H, Lamb M, Kurylko G, Hamid R, Wright MB, Pamidimukkala A, Egan T, Gubler U, Hoffman AF, Wei X, Li YL, O'Neil J, Marcano R, Pozzani K, Molinaro T, Santiago J, Singer L, Hargaden M, Moore D, Catala AR, Chao LC, Hermann G, Venkat R, Mancebo H, Renzetti LM.. (2010) Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1., 53 (9): [PMID:20380377 ] [10.1021/jm1001919 ]